Parallel Synthesis of 1H-Pyrazolo[3,4-d]pyrimidines via Condensation of N-Pyrazolylamides and Nitriles

Triflic Anhydride (Tf2O)-Activated Transformations of Amides, Sulfoxides and Phosphorus Oxides via Nucleophilic Trapping

Trifluoromethanesulfonic anhydride (Tf2O) is utilized as a strong electrophilic activator in a wide range of applications in synthetic organic chemistry, leading to the transient generation of a triflate intermediate. This versatile triflate intermediate undergoes nucleophilic trapping with diverse nucleophiles to yield novel compounds. In this review, we describe the features and applications of triflic anhydride in organic synthesis reported in the past decade, especially in amide, sulfoxide, and phosphorus oxide chemistry through electrophilic activation. A plausible mechanistic pathway for each important reaction is also discussed.

1 Introduction

2 Amide Chemistry

2.1 Carbon Nucleophiles

2.2 Hydrogen Nucleophiles

2.3 Nitrogen Nucleophiles

2.4 Oxygen and Sulfur Nucleophiles

2.5 hosphorus Nucleophiles

2.6 A Vilsmeier-Type Reagent

2.7 Umpolung Reactivity in Amides

3 Sulfoxide Chemistry

3.1 Oxygen Nucleophiles

3.2 Carbon Nucleophiles

3.3 Nitrogen Nucleophiles

3.4 Thionium Reagents

4 Phosphorus Chemistry

4.1 Hendrickson’s Reagent

4.2 Diaryl Phosphine Oxides

4.3 Phosphonates, Phosphates and Phosphinates

5 Conclusion and Outlook

Pyrimidine-fused Dinitrogenous Penta-heterocycles as a Privileged Scaffold for Anti-Cancer Drug Discovery

Pyrimidine-fused derivatives that are the inextricable part of DNA and RNA play a key role in the normal life cycle of cells. Pyrimidine-fused dinitrogenous penta-heterocycles including pyrazolopyrimidines and imidazopyrimidines is a special class of pyrimidine-fused compounds contributing to an important portion in anti-cancer drug discovery, which have been discovered as core structure for promising anti-cancer agents used in clinic or clinical evaluations. Pyrimidine-fused dinitrogenous penta-heterocycles have become one privileged scaffold for anti-cancer drug discovery. This review consists of the recent progress of pyrimidine-fused dinitrogenous penta-heterocycles as anti-cancer agents and their synthetic strategies. In addition, this review also summarizes some key structure-activity relationships (SARs) of pyrimidine-fused dinitrogenous penta-heterocycle derivatives as anti-cancer agents.